Odyssey Health (ODYY) Enterprise Value Growth (1y) (2015 - 2026)
Odyssey Health (ODYY) Enterprise Value Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -9,247.33% |
| Jan 31, 2026 | -8,475.58% |
| Oct 31, 2025 | 52.50% |
| Jul 31, 2025 | -702.19% |
| Apr 30, 2025 | 95.17% |
| Jan 31, 2025 | 95.67% |
| Oct 31, 2024 | 72.78% |
| Jul 31, 2024 | 93.55% |
| Apr 30, 2024 | -5,249.59% |
| Jan 31, 2024 | -364.18% |
| Oct 31, 2023 | -291.85% |
| Jul 31, 2023 | 49.18% |
| Apr 30, 2023 | 99.54% |
| Jan 31, 2023 | 72.75% |
| Oct 31, 2022 | 89.28% |
| Jul 31, 2022 | 0.00% |
| Apr 30, 2022 | 80.68% |
| Jan 31, 2022 | -108.23% |
| Oct 31, 2021 | -60.93% |
| Jul 31, 2021 | 86.97% |